The overall aim is to design, prepare and evaluate novel nanoparticle/microneedle array patch (MAP) combinations for prevention of HIV infection. The key objectives are:
Design, produce and characterise dissolving microneedles
Combine long-acting anti-retroviral nanoparticles and microneedles in composite MAPs
Study MAP performance in vitro and extrapolate to human treatment
Where is this data from?
This data was originally published by
The Wellcome Trust.
If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a
grantee amendment request.
You can hover over codes from
standard codelists
to see the user-friendly name provided by 360Giving.
360Giving uses privacy-respecting analytics. If you don't
accept cookies, we will track only basic information about your visit. Click "Disable Analytics" if you don't
want us to track at all.